Disodium Pyrophosphate

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
166	弾性線維性仮性黄色腫	2

166. 弾性線維性仮性黄色腫

臨床試験数 : 16 / 薬物数 : 27 - (DrugBank : 5) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 28

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04441671 (ClinicalTrials.gov)	December 8, 2020	20/1/2020	Oral Pyrophosphate Absorption in PXE Disease	Oral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum (PXE)	Pseudoxanthoma Elasticum	Drug: Disodium Pyrophosphate	Tampere University Hospital	UMC Utrecht;Hungarian Academy of Sciences	Withdrawn	18 Years	80 Years	All	0	Phase 2	NULL
2	EUCTR2019-002109-24-FI (EUCTR)	01/08/2019	01/07/2019	Oral Pyrophosphate Absorption in PXE Disease	Oral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum - Oral PyrophosphateAbs ...	Pseudoxanthoma elasticum;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Disea ...	Product Name: Disodiumpyrophosphate	Tampere University Hospital	NULL	Not Recruiting			Female: yes Male: yes	10	Phase 2	Finland

First Previous1Next Last